Improved TissueFect™ technology means
Explore this white paper to learn how you can benefit from the enhanced TissueFect™ technology within the Valleylab™ FT10 energy platform.
Authors:
Jim Dunning, Staff Development Engineer, Medtronic
Katherine Wagle, Senior Development Engineer, Medtronic
Ad and Webpage References:
1. As compared to the ForceTriad™ energy platform. Ex-vivo testing model used to evaluate monopolar performance. Based on Covidien ex-vivo monopolar report: “Verification - report - Ex-vivo Monopolar Procedural Flow Evaluation on the Valleylab™ FT10 Orion.” November 2014; R0064443 Rev A.
2. As compared to the ForceTriad™ energy platform. Bench testing model used to evaluate sealing time. Based on Covidien memo: “LigaSure Data Sources for VLFT10 White Papers.” September
2015; RE00025819 Rev A.
3. As compared to the ForceTriad™ energy platform. Based on Covidien product verification report: “Autobipolar Evaluation - Valleylab™ FT10”; February 2015; RE0064455.
4. As compared to the ForceTriad™ energy platform. Bench testing model used to evaluate sealing time. Based on Covidien memo: “LigaSure Data Sources for VLFT10 White Papers.” September
2015; RE00025819 Rev A.>
*Ad Only Reference: Based on the Valleylab™ FT10 Service Manual: part number 1079477, REV 01/2015